Member Info for researcher1

the first approach was certainly flawed, but it is my understanding that this time the FDA have been consulted all along, and the additional questions that have been addressed this year are part of that. With a 'Q' approach, given the weight of evidence across the globe of Parsortix's world-leading performance in both accuracy and precision, the submission will have been de-risked around March. Meanwhile sales for research use have reached the several hundreds. If and when Parsortix becomes the world leader, what share of $100B might we expect...?

you are deliberately missing the point that the process has in fact now started
what's up? looking for a lower entry point?
check out ANs personal holding if you think he's laughing at us

the other point about the 'Q' process is that the decision will be de-risked months in advance. That's why it is risky trading from now on - there has to be a gradual step up to a decent launch SP. Year 1 sales will be greater than the MCAP!

and even though it's the FDA, the process will be a lot faster!

is there a mouse in your clock hicory? Today is the first day of the FDA process - the brexit equivalent of the Withdrawal agreement being signed.

agree with you all, to an extent. Sold some this morning but, after reflecting, have started buying back now. The thing is, the SP should be around 140-160 prior to submission (if all goes smoothly) because it will move into in the £3 range on approval, and AN's bonus scheme anticipates a £4+ sp. So the question is, at what point does it begin to step up to that 'launch' level? There are plenty of hungry US investors who didn't get their allocation etc. So I intend to buy another £50K (seriously raising my average) before January.

the logic of the fall is: Lithium has fallen in price by 50% over the past year, and is still dropping.

I sold at 79 so definitely buy back time for me.

thinking of selling today + 15%. I have no idea where it will go next but it doesn't feel like the 'free money' it did at 68p...

back in healthy profit again. I managed to get some at 46p to add to the 62p ones, so very happy today.

excellent report - Parsortix is the world leader in the most important medical arena (early detection). I'm buying up to £1.10 prior to FDA clearance. (so obviously filling my boots today)

decided to sell @ 4.71 as £3K profit more than makes up for earlier losses. GLA I hope it continues to rise.

you're right! my buy on TDW at 3.58 was improved by 0.03 points (so it was 3.61 at the time)

Sorry to all LTH here. I used to be a firm holder too (living just over the moor) but sold around 20p when the finance wobbles began. Got in this morning at 3.5p just for the heck of it. Probably will hope it gets to 7p then sell.

yes, had hoped for 100 by this morning, but (politics notwithstanding) it shouldn't be long.

sp will probably only flicker at this extra bonus news, but if the weekend press have an intelligent think about all the groundbreaking developments Angle have lined up, Monday might just be the day the sp gaps up to where it should be (100+)

and that 135 target is a joke - AN's own share option incentives imply he's looking at a £4 share price post FDA (not instantly obviously)

104 is absolute minimum just prior to FDA submission IMO
(i.e. now!)
but all the developments suggest it should be higher - 18 month turnaround for tests in clinics for ovarian, prostate etc - I'm thinking, 10,000 machines in the UK alone - £5M no commission... what's not to like...

hopefully when the US reads it, they will recognise the value....

will the market wake up to this I wonder? - it is obsessed with FDA clearance, but as far as I can see, that is now a dead cert - medicine needs Parsortix asap.